Baxter Articles
Xoma and Baxter see delayed Neuprex filing
26 April 2000
Baxter's NAV acquisition agreement amended
19 April 2000
Bayer wins positive opinion for Kogenate
28 March 2000
Baxter to invest $400 million in facilities
23 March 2000
ML Labs defends itself against icodextrin study
16 March 2000
Cerus raises $25 million
21 February 2000
Baxter acquires global rights to Xoma's Neuprex
27 January 2000
Stock Commentary Tokyo
27 January 2000
North American Vaccine to file for NeisVac-C OK
20 January 2000
New chairman at Baxter
25 November 1999
BioChem sells NAV stake to Baxter
25 November 1999
BioChem sells NAV stake to Baxter
19 November 1999
Pharma Alliance for Y2K Readiness website
26 August 1999
Ivax bids for rest of Czech firm Galena
21 May 1999
European launch of BeneFIX
2 February 1999
Enzon - improving the delivery and side effect profile of proven
20 January 1999
Losses deepen at ML Laboratories
18 January 1999
Gensia plans generic propofol launch in '99
13 January 1999
B-MS To Take Up To $500M 4th-Qtr Charge
18 November 1998
Latest Wave Of US 1st Quarter Results
29 October 1998
Baxter Healthcare's manufacturing facility gets FDA ok
29 October 1998
CellPro Files For Bankruptcy, Sells Assets, Lawsuit Settled
1 October 1998
Baxter Drops Blood Substitute
17 September 1998
Substitute As Good As Blood In Trauma Patients
12 August 1998
Healthy Second-Quarter Growth For US Drug Firms
29 July 1998
US Product Liability Bill "Is Dead"
14 July 1998
Drugmakers Uncertain Of French Govt Intentions
10 July 1998
ML Labs Slips Into Red, High Hopes For Icodial
2 July 1998
Taiwan HIV Hemophiliacs Settle With Bayer
15 June 1998
Baxter Suspends HemAssist Trial In Europe
4 June 1998
Corixa And CellPro Terminate Alliance
30 April 1998
Net Income Rises 10% At Baxter
30 April 1998
Immune Globulin Shortage: Are Companies Hoarding?
30 April 1998
Baxter Completes Acquisition of Ohmeda
9 April 1998
Baxter's HemAssist Fails In Phase III Trauma Study
1 April 1998
FDA Approvals In Brief
11 March 1998
Baxter Set To Acquire Somatogen
26 February 1998
Appointment At Baxter
19 February 1998
CellPro To Continue Making Products Outside USA
10 February 1998
Trend For 1997 Strong Sales Continues In USA
5 February 1998
Baxter to Acquire Ohmeda Division
29 January 1998
Moratorium In Xenotransplantation Urged
28 January 1998
US Biotech Ends Year "Slightly Ahead" Of 1996
21 January 1998
VIMRX & Baxter Set Up Cell Therapy Co
12 January 1998
Majors Moving Away From Acquisitions & Mergers
12 January 1998
Majors Moving Away From Acquisitions & Mergers
6 January 1998
Baxter's Bieffe Medital Acquisition OKed
6 January 1998
Trials Delayed At ML Labs, Shares Drop
18 December 1997
Shield Close To Signing Marketing Deal For AFT
17 December 1997
Ares-Serono Buys GW Geneva R&D Center
27 November 1997
Clinical Trials Update
19 November 1997
US 3rd Qtr Corporate Results Round-Up
30 October 1997
Drug Majors Subpoenaed
29 October 1997
Healthy 3rd Qtr For Inhale Therapeutics
15 October 1997
GI's Benefix Approved By EMEA
9 October 1997
Growing Foreign Presence In China's Pharma Industry
22 September 1997
NIH "Will Not Intervene" In CellPro Patent Dispute
7 August 1997
Smaller US Firms' Losses Grow Due To R&D Costs
31 July 1997
$7m Awarded Against CellPro In Patent Case
31 July 1997
Progress At ML Labs In First Half
2 July 1997
Appointment at Baxter International
19 May 1997
Appointment At Baxter International
21 April 1997
Performance Still Sought From US Biotech Stocks
21 April 1997
Northfield Labs' Blood Substitute In Ph III
9 April 1997
US Jury Awards $2.3m Against CellPro In Patent Dispute
17 March 1997
Hemosol's Blood Substitute Begins Ph II
10 March 1997
Genetics Institute's Factor IX Approved In 1st Market
17 February 1997
Strong Earnings Continue At Major US Drug Firms
10 February 1997
Acquisitions And Mergers Continue, Led By Novartis
6 January 1997
Baxter To Acquire Research Medical
9 December 1996
Genentech/Baxter Alliance
9 December 1996
Baxter's HemAssist Enters Ph III
9 December 1996
Companies Move On Hemophiliacs' HIV Settlement
9 December 1996
US Quarterly Results Show Improvements
4 November 1996
Cytel And Nextran To Develop Xenotransplant Product
28 October 1996
Centeon Albumin Recall Hits R-PR
21 October 1996
EU Approves Baxter's Takeover Of Immuno
21 October 1996
Appointment At Ergo Science
30 September 1996
Industry/Health Service Partnerships Viewed
23 September 1996
New York Stock Comment
9 September 1996
Abbott, Baxter Boost US Democrats' Funds
9 September 1996
Baxter International To Acquire Immuno AG
9 September 1996
Single-Digit Profits Growth For B-MS And W-L
5 August 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
Baxter's Hem-Assist To Enter Phase III Trials
1 July 1996
Baxter Deal With ML On Dialysis Solution
1 July 1996
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
